November 12, 2021 6:54 pm
Johnson & Johnson said it will separate its consumer health business into a new publicly traded company echoing a move by rivals GlaxoSmithKline plc and Pfizer Inc which plan to spin off their joint consumer health business next year.
October 17, 2021 9:59 am
Third doses of the Pfizer-BioNTech and Moderna vaccines also have been authorized for some people with weaker immune systems, who may not have gotten full protection from the original two doses.
October 05, 2021 4:59 pm
The filing comes after the FDA last week scheduled an Oct. 15 meeting of its expert advisory committee to discuss whether to authorize a second shot of J&J's single-dose vaccine.
October 01, 2021 6:31 pm
EMA said the new, possibly life-threatening clotting condition known as venous thromboembolism (VTE) to be included on the J&J product label was separate from TTS.
September 16, 2021 7:14 am
However, top government sources said the government has still not granted indemnity against the cost of compensation for adverse side effects due to vaccination, as sought by Johnson & Johnson.
August 20, 2021 11:26 am
The transition will put the world's largest drugmaker by market value in the hands of a company veteran who took a leading role in J&J's COVID-19 response and helped shape its pharmaceutical business strategy.
August 17, 2021 10:16 am
Johnson & Johnson has been exporting millions of doses that were bottled and packaged in South Africa for distribution in Europe, according to executives at Johnson & Johnson and the South African manufacturer, Aspen Pharmacare, as well as South African government export records reviewed by The New York Times.
August 06, 2021 12:50 pm
A South African study has shown the Johnson & Johnson COVID-19 vaccine offers over 90% protection against death
July 22, 2021 8:43 am
McKesson will pay up to $7.9 billion, while AmerisourceBergen and Cardinal each agreed to provide up to $6.4 billion. The payments will be made over 18 years.
July 21, 2021 1:02 pm
The delta variant is the most contagious version yet of the coronavirus. It accounts for 83% of infections in the United States, Dr. Rochelle Walensky, director of the Centers for Disease Control and Prevention, said.